NOX5: Molecular biology and pathophysiology

Area of Science:

• Biochemistry and Molecular Biology
• Physiology
• Pathology

Background:

• Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (Nox) are key producers of reactive oxygen species (ROS) involved in cell signaling.
• NOX5 is a unique isoform, lacking in rodents, regulated by Ca2+, and not requiring accessory subunits for activation.
• NOX5 dysregulation is linked to cardiovascular disease, kidney injury, and cancer.

Purpose of the Study:

• To provide a comprehensive overview of Nox5 biology, from basic science to human disease.
• To highlight recent advances in Nox5 research, including its crystal structure and pathophysiological roles.
• To discuss the therapeutic potential of targeting Nox5.

Main Methods:

• Review of existing literature on Nox5.
• Analysis of recent discoveries, including crystal structure determination.
• Examination of genome-wide association studies (GWAS) and mouse models.

Main Results:

• The crystal structure of Nox5 has been elucidated, enabling isoform-specific drug development.
• GWAS identified Nox5 as a gene associated with blood pressure.
• Studies in mice reveal Nox5's role in vascular contraction and kidney function, with increased activity in cardiovascular disease and diabetic nephropathy.

Conclusions:

• Nox5 is a critical regulator of vascular and kidney function, with its hyperactivation contributing to disease.
• The unique structural and regulatory features of Nox5 present opportunities for targeted therapies.
• Further research into Nox5 biology is warranted given its emerging role in human health and disease.